Group structure
4 companies in 2 countries
Netherlands1
United States1
Headquarters not stated2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
11 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ARIKAYCE KIT590mg base/8.4ml · Suspension, liposomal | Amikacin | United States | Marketed | 2018 |
| Arikayce liposomaal 590 mg dispersie voor vernevelaarVernevelsuspensie | Amikacin | Netherlands | Authorised | 2020 |
| Arikayce liposomal | Amikacin | EU (EMA) | Authorised | 2020 |
| ARIKAYCE LIPOSOMIALEDispersione per nebulizzatore | Amikacin | Italy | Authorised | |
| Brinsupri | Brensocatib | EU (EMA) | Authorised | 2025 |
| BRINSUPRI10mg | 25mg · Tablet | Brensocatib | United States | Marketed | 2025 |
| BRINSUPRICompressa rivestita con film | Brensocatib | Italy | Authorised | |
| Brinsupri 25 mg filmomhulde tablettenFilmomhulde tablet | Brensocatib | Netherlands | Authorised | 2025 |
| IPLEX36mg/0.6ml · Injectable | Mecasermin rinfabate recombinant | United States | Not marketed | 2005 |
| Arikayce | Amikacin | EU (EMA) | Refused | |
| Iplex | Mecasermin rinfabate | EU (EMA) | Refused |